Akram A. Hosseini
Magnetic resonance imaging plaque hemorrhage for risk stratification in carotid artery disease with moderate risk under current medical therapy
Hosseini, Akram A.; Simpson, Richard J.; Altaf, Nishath; Bath, Philip M.W.; MacSweeney, Shane T.; Auer, Dorothee P.
Authors
Richard J. Simpson
Nishath Altaf
Philip M.W. Bath
Shane T. MacSweeney
Dorothee P. Auer
Abstract
Background and Purpose—Magnetic resonance imaging (MRI)–defined carotid plaque hemorrhage (MRIPH) can predict recurrent cerebrovascular ischemic events in severe symptomatic carotid stenosis. It is less clear whether MRIPH can improve risk stratification despite optimized medical secondary prevention in those with moderate risk.
Methods—One-hundred fifty-one symptomatic patients with 30% to 99% carotid artery stenosis (median age: 77, 60.5% men) clinically deemed to not benefit from endarterectomy were prospectively recruited to undergo MRI and clinical follow-up (mean, 22 months). The clinical carotid artery risk score could be evaluated in 88 patients. MRIPH+ve was defined as plaque intensity >150% that of adjacent muscle. Survival analyses were performed with recurrent infarction (stroke or diffusion-positive cerebral ischemia) as the main end point.
Results—Fifty-five participants showed MRIPH+ve; 47 had low, 36 intermediate, and 5 high carotid artery risk scores. Cox regression showed MRIPH as a strong predictor of future infarction (hazard ratio, 5.2; 95% confidence interval, 1.64–16.34; P=0.005, corrected for degree of stenosis), also in the subgroup with 50% to 69% stenosis (hazard ratio, 4.1; 95% confidence interval, 1–16.8; P=0.049). The absolute risk of future infarction was 31.7% at 3 years in MRIPH+ve versus 1.8% in patients without (P<0.002). MRIPH increased cumulative risk difference of future infarction by 47.1% at 3 years in those with intermediate carotid artery risk score (P=0.004).
Conclusions—The study confirms MRIPH to be a powerful risk marker in symptomatic carotid stenosis with added value over current risk scores. For patients undergoing current secondary prevention medication with clinically uncertain benefit from recanalization, that is, those with moderate degree stenosis and intermediate carotid artery risk scores, MRIPH offers additional risk stratification.
Citation
Hosseini, A. A., Simpson, R. J., Altaf, N., Bath, P. M., MacSweeney, S. T., & Auer, D. P. (2017). Magnetic resonance imaging plaque hemorrhage for risk stratification in carotid artery disease with moderate risk under current medical therapy. Stroke, 48(3), https://doi.org/10.1161/STROKEAHA.116.015504
Journal Article Type | Article |
---|---|
Acceptance Date | Dec 21, 2016 |
Publication Date | Feb 14, 2017 |
Deposit Date | Mar 8, 2018 |
Publicly Available Date | Mar 8, 2018 |
Journal | Stroke |
Print ISSN | 0039-2499 |
Electronic ISSN | 1524-4628 |
Publisher | American Heart Association |
Peer Reviewed | Peer Reviewed |
Volume | 48 |
Issue | 3 |
DOI | https://doi.org/10.1161/STROKEAHA.116.015504 |
Keywords | atherosclerotic plaque; carotid stenosis; cerebral infarction; endarterectomy; magnetic resonance imaging; stroke |
Public URL | https://nottingham-repository.worktribe.com/output/845857 |
Publisher URL | http://stroke.ahajournals.org/content/48/3/678 |
Contract Date | Mar 8, 2018 |
Files
ACCEPTED MANUSCRIPT - MRI plaque hemorrhage for risk stratification in carotid artery disease with moderate risk under current medical therapy.pdf
(431 Kb)
PDF
You might also like
Mapping brain endophenotypes associated with idiopathic pulmonary fibrosis genetic risk
(2022)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search